ODDB.org: Open Drug Database | Drugs

Pfizer AG - Zirabev 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	67501	Sequence	01
Product name	Zirabev 100 mg/4 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FG01	ATC-Description
Introduction of Sequence	10.05.2020

Composition

bevacizumabum 100 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 2.32 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Bevacizumab	100mg / 4ml

BAG: Active Agent	Dose
Bevacizumab	100 mg

Inactive agents
Succinic Acid
Dinatrii Edetas
Sodium Hydroxide
Polysorbatum 80
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		257.57	296.55	A	SL	Yes

2025	©ywesee GmbH